Suppr超能文献

基于tRNA/前体微小RNA的重组非编码RNA的表达与纯化

Expression and Purification of tRNA/ pre-miRNA-Based Recombinant Noncoding RNAs.

作者信息

Tu Mei-Juan, Wright Halley K, Batra Neelu, Yu Ai-Ming

机构信息

Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA, USA.

出版信息

Methods Mol Biol. 2021;2323:249-265. doi: 10.1007/978-1-0716-1499-0_18.

Abstract

Research on RNA function and therapeutic potential is dominated by the use of chemoengineered RNA mimics. Recent efforts have led to the establishment of novel technologies for the production of recombinant or bioengineered RNA molecules, which should better recapitulate the structures, functions and safety profiles of natural RNAs because both are produced and folded in living cells. Herein, we describe a robust approach for reproducible fermentation production of bioengineered RNA agents (BERAs) carrying warhead miRNAs, siRNAs, aptamers, or other forms of small RNAs, based upon an optimal hybrid tRNA/pre-miRNA carrier. Target BERA/sRNAs are readily purified by fast protein liquid chromatography (FPLC) to a high degree of homogeneity (>97%). This approach offers a consistent high-level expression (>30% of total bacterial RNAs) and large-scale production of ready-to-use BERAs (multiple to tens milligrams from 1 L bacterial culture).

摘要

RNA功能及治疗潜力的研究主要依赖于化学工程改造的RNA模拟物。最近的研究成果催生了用于生产重组或生物工程RNA分子的新技术,这些技术有望更好地模拟天然RNA的结构、功能和安全性,因为它们都是在活细胞中产生并折叠的。在此,我们描述了一种基于优化的杂交tRNA/前体miRNA载体,可重复性发酵生产携带弹头miRNA、siRNA、适体或其他形式小RNA的生物工程RNA制剂(BERA)的稳健方法。目标BERA/小RNA可通过快速蛋白质液相色谱(FPLC)轻松纯化至高度均一性(>97%)。该方法可实现稳定的高水平表达(>细菌总RNA的30%),并大规模生产即用型BERA(从1升细菌培养物中可获得数毫克至数十毫克)。

相似文献

5
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.基于 RNAi 的治疗方法和新型 RNA 生物工程技术。
J Pharmacol Exp Ther. 2023 Jan;384(1):133-154. doi: 10.1124/jpet.122.001234. Epub 2022 Jun 9.
6
Molecular Engineering of Functional SiRNA Agents.功能性 siRNA 试剂的分子工程。
ACS Synth Biol. 2024 Jun 21;13(6):1906-1915. doi: 10.1021/acssynbio.4c00181. Epub 2024 May 11.
8
Novel approaches for efficient  in vivo fermentation production of noncoding RNAs.新型高效非编码 RNA 体内发酵生产方法。
Appl Microbiol Biotechnol. 2020 Mar;104(5):1927-1937. doi: 10.1007/s00253-020-10350-3. Epub 2020 Jan 17.

引用本文的文献

1
In Vivo Fermentation Production of RNA Interference Agents.RNA干扰剂的体内发酵生产
Methods Mol Biol. 2025;2965:489-500. doi: 10.1007/978-1-0716-4742-4_26.
2
The Precise Basecalling of Short-Read Nanopore Sequencing.短读长纳米孔测序的精确碱基识别
bioRxiv. 2024 Sep 17:2024.09.12.612746. doi: 10.1101/2024.09.12.612746.

本文引用的文献

5
Therapeutic Antisense Oligonucleotides Are Coming of Age.治疗性反义寡核苷酸渐趋成熟。
Annu Rev Med. 2019 Jan 27;70:307-321. doi: 10.1146/annurev-med-041217-010829.
6
Treating Disease at the RNA Level with Oligonucleotides.用寡核苷酸在RNA水平治疗疾病。
N Engl J Med. 2019 Jan 3;380(1):57-70. doi: 10.1056/NEJMra1705346.
7
RNA therapy: Are we using the right molecules?RNA 疗法:我们使用的分子正确吗?
Pharmacol Ther. 2019 Apr;196:91-104. doi: 10.1016/j.pharmthera.2018.11.011. Epub 2018 Dec 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验